<PAGE> 1
================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (date of earliest event reported): October 24, 2000
GENENTECH, INC.
(Exact name of registrant as specified in its charter)
<TABLE>
<S> <C> <C>
Delaware 94-2347624
(State of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.
001-09813
1 DNA Way
South San Francisco, California 94080-4990
(Address of Principal Executive Offices) (Zip Code)
</TABLE>
--------------
Genentech, Inc.
1 DNA Way
South San Francisco, California 94080-4990
(Address of Principal Executive Offices)
(650) 225-1000
(Registrant's Telephone Number, Including Area Code)
<PAGE> 2
INFORMATION TO BE INCLUDED IN THE REPORT
ITEM 5: OTHER EVENTS
Genentech, Inc. has effected a 2-for-1 stock split in the form of a stock
dividend. The record date of such stock split was October 17, 2000, meaning that
shareholders of record of Genentech common stock at the close of business on
that date became entitled to receive one additional share of Genentech common
stock for each share held. The additional shares were distributed on October 24,
2000.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
GENENTECH, INC.
Date: October 25, 2000 By: /s/ Arthur D. Levinson
-----------------------------
Name: Arthur D. Levinson, Ph.D.
Title: Chairman and Chief Executive Officer
